Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ingeborg M. Bachmann"'
Autor:
Erik Mørk, Patricia Mjønes, Olav A. Foss, Cato Mørk, Ingeborg M. Bachmann, Susanne Kroon, Lars K. Dotterud, Per Helsing, Øystein Vatne, Eidi Christensen
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Photodynamic therapy is an approved treatment for primary, superficial, and small nodular basal cell carcinomas with a thickness of < 2 mm located on low-risk sites. Histologically verified basal cell carcinomas clinically assessed as suited for phot
Externí odkaz:
https://doaj.org/article/6feba8f69d10446dafab9d6e8a67373b
Publikováno v:
Journal of Histochemistry & Cytochemistry. 71:111-120
Photodynamic therapy (PDT) is an effective and cosmetically beneficial treatment of low-risk basal cell carcinomas (BCCs). To optimize PDT response, it is important to correctly select tumors. We sought to find markers that could identify such tumors
Autor:
Hanne Sommerfelt, Lene F. Sandvik, Ingeborg M. Bachmann, Ragnvald Ljones Brekke, Henrik Løvendahl Svendsen, Anne Berit Guttormsen, Sura Aziz, Hanna Dillekås, Oddbjørn Straume
Publikováno v:
Acta Oncologica. 61:1295-1299
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210399 (2019)
Angiogenesis is important for the progression of cutaneous melanoma. Here, we analyzed the prognostic impact of the angiogenic factor urokinase plasminogen activator resecptor (uPAR), vascular proliferation index (VPI) and tumor necrosis as a measure
Externí odkaz:
https://doaj.org/article/a3a121d980784a19a8245be4a4285f08
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 1, p e0210399 (2019)
PLoS ONE, Vol 14, Iss 1, p e0210399 (2019)
Angiogenesis is important for the progression of cutaneous melanoma. Here, we analyzed the prognostic impact of the angiogenic factor urokinase plasminogen activator resecptor (uPAR), vascular proliferation index (VPI) and tumor necrosis as a measure
Autor:
R Banerjee, M.A. de Rie, J Frueh, Mona Ståhle, P.C.M. van de Kerkhof, Lars Iversen, Amra Osmancevic, Liv Eidsmo, Joar Austad, Toomas Talme, Lone Skov, A E R Fasth, Ingeborg M. Bachmann, J Oliver
Publikováno v:
JEADV : Journal of the European Academy of Dermatology and Venereology, 32, 11, pp. 1930-1939
JEADV : Journal of the European Academy of Dermatology and Venereology, 32, 1930-1939
Iversen, L, Eidsmo, L, Austad, J, de Rie, M, Osmancevic, A, Skov, L, Talme, T, Bachmann, I, van de Kerkhof, P, Stahle, M, Banerjee, R, Oliver, J, Fasth, A E R & Frueh, J 2018, ' Secukinumab treatment in new-onset psoriasis : Aiming to understand the potential for disease modification-rationale and design of the randomized, multicenter STEPIn study ', Journal of the European Academy of Dermatology and Venereology, vol. 32, no. 11, pp. 1930-1939 . https://doi.org/10.1111/jdv.14979
Journal of the European Academy of Dermatology and Venereology, 32(11), 1930-1939. Wiley-Blackwell
JEADV : Journal of the European Academy of Dermatology and Venereology, 32, 1930-1939
Iversen, L, Eidsmo, L, Austad, J, de Rie, M, Osmancevic, A, Skov, L, Talme, T, Bachmann, I, van de Kerkhof, P, Stahle, M, Banerjee, R, Oliver, J, Fasth, A E R & Frueh, J 2018, ' Secukinumab treatment in new-onset psoriasis : Aiming to understand the potential for disease modification-rationale and design of the randomized, multicenter STEPIn study ', Journal of the European Academy of Dermatology and Venereology, vol. 32, no. 11, pp. 1930-1939 . https://doi.org/10.1111/jdv.14979
Journal of the European Academy of Dermatology and Venereology, 32(11), 1930-1939. Wiley-Blackwell
Background: To date, biological treatments have been assessed in subjects with a long-term history of psoriasis and previous failures to systemic and topical therapies. In rheumatoid arthritis and other immune-mediated inflammatory diseases, early in
Publikováno v:
Modern Pathology. 27:396-401
The intermediate filament nestin, a neural stem-cell marker, is reported to be expressed more strongly in melanomas compared with benign melanocytic lesions, and increasingly expressed in advanced melanoma stages. However, the prognostic impact of ne
Autor:
Ingeborg M. Bachmann, Jürgen Geisler, Hans E. Fjøsne, Trude Eid Robsahm, Marta Nyakas, Lars A. Akslen, Kari D. Jacobsen, Lovise Maehle, Nils Eide, Per Helsing, Oddbjørn Straume, Henrik L. Svendsen, Steinar Aamdal
Publikováno v:
Tidsskrift for Den norske legeforening. 133:2154-2158
Background The incidence of malignant melanoma in Norway is among the highest in the world and rising, with approximately 1 500 persons receiving the diagnosis annually. Correct surgical primary treatment cures 80-90%, while 10-20% experience relapse
Publikováno v:
American Journal of Surgical Pathology. 36:1477-1482
The significance of tumor necrosis in cutaneous melanoma has not been well elucidated. The purpose of this study was to explore the prognostic impact of necrosis in comparison with other known clinicopathologic factors in these tumors. Initially, 457
Autor:
Oddbjørn Straume, Anders Molven, Lars A. Akslen, Hanne E. Puntervoll, Edda Vuhahula, Ingeborg M. Bachmann, Rajesh Kumar
Publikováno v:
Melanoma Research. 18:29-35
Earlier studies have shown frequent mutations in the BRAF and NRAS genes in cutaneous melanoma, but these alterations have not been examined in the rare category of melanoma from black Africans. Moreover, the frequency of epidermal growth factor rece